Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide

BACKGROUND: This analysis aims to evaluate health-related quality of life (HrQoL) (primary outcome for this analysis), nausea and vomiting, and pain in patients with inoperable malignant bowel obstruction (IMBO) due to cancer or its treatments randomised to standardised therapies plus octreotide or...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:BMC Cancer
المؤلفون الرئيسيون: McCaffrey, Nikki, Asser, Tegan, Fazekas, Belinda, Muircroft, Wendy, Agar, Meera, Clark, Katherine, Eckermann, Simon, Lee, Jessica, Joshi, Rohit, Allcroft, Peter, Sheehan, Caitlin, Currow, David C.
التنسيق: Artigo
اللغة:Inglês
منشور في: BioMed Central 2020
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7603764/
https://ncbi.nlm.nih.gov/pubmed/33129304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07549-y
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة